NM
Nagaraj Manickam
Madras Diabetes Research Foundation, The University of Texas Health Science Center at San Antonio, University of Madras
0000-0002-0049-777X
Employment
-
Madras Diabetes Research Foundation Scientist and Head2010 - Present
-
The University of Texas Health Science Center at San Antonio Post Doctoral Fellow2004 - 2010
Education
-
University of Madras PhD1998 - 2003
-
University of Madras M.Phil1997 - 1998
Projects & Funding
Projects & funding information is unavailable.
Publications (16)
- Metformin Reduces the Progression of Atherogenesis by Regulating the Sestrin2-mTOR Pathway in Obese and Diabetic Rats Save
- Aegeline mitigates high glucose induced renal cell fibrosis by alleviating ROS generation & augmenting hydrogen sulphide Save
- Asymmetric Dimethylarginine and 20-Hydroxyeicosatetraenoic Acid - A lethal combo in diabetic kidney disease Save
- Augmentation of RBP4/STRA6 signaling leads to insulin resistance and inflammation and the plausible therapeutic role of vildagliptin and metformin Save
- Decreased Sestrin levels in patients with type 2 diabetes and dyslipidemia and their association with the severity of atherogenic index Save
- Acceptability and Utilization of Newer Technologies and Effects on Glycemic Control in Type 2 Diabetes: Lessons Learnt from Lockdown Save
- Asymmetric dimethylarginine (ADMA) accelerates renal cell fibrosis under high glucose condition through NOX4/ROS/ERK signaling pathway Save
- Plausible diagnostic value of urinary isomeric dimethylarginine ratio for diabetic nephropathy Save
- Sestrin2 regulates monocyte activation through AMPK-mTOR nexus under high-glucose and dyslipidemic conditions Save
- Association of circulatory asymmetric dimethylarginine (ADMA) with diabetic nephropathy in Asian Indians and its causative role in renal cell injury Save